Team:UT Dallas/Protocols

From 2011.igem.org

(Difference between revisions)
Line 468: Line 468:
             <li><a href="https://2011.igem.org/Team:UT_Dallas"><font size="3" face="verdana">Home</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas"><font size="3" face="verdana">Home</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Project"><font size="3" face="verdana">Team</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Project"><font size="3" face="verdana">Team</a></font></li>
-
             <li class = "active"><a href="https://2011.igem.org/Team:UT_Dallas/Project2"><font size="4" face="verdana">Project</a></font></li>
+
             <li class = "active"><a href="https://2011.igem.org/Team:UT_Dallas/Project2"><font size="3" face="verdana">Project</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Protocols"><font size="4" face="verdana">Protocols</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Protocols"><font size="4" face="verdana">Protocols</a></font></li>

Revision as of 22:44, 17 July 2011

biz solution

UTD iGem 2011 Project Description

Tissue damage characterizes a range of medical conditions that can be particularly difficult to manage without restrictively risky or expensive intervention. The human body hosts a rich diversity of symbiotic microflora that provides a powerful engineering platform for synthetic bacterial systems. We aim to construct a probiotic solution that successfully interfaces with the immune system to facilitate localized tissue repair.